PetMed Express (PETS) Stock Price, News & Analysis

Company Overview

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Key Stats

• Today's Range: $4.69 to $4.85
• 50-Day Range: $3.49 to $5.73
• 52-Week Range: $2.90 to $7.90
• Volume: 144,748 shs
• Average Volume: 340,102 shs
• Market Capitalization: $98.75 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.50
• Consensus Rating: Reduce

PetMed Express Stock Analysis - MarketRank™

PetMed Express scored higher than 7% of companies evaluated by MarketBeat, and ranked 205th out of 210 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.8 / 5
• Analyst Rating: Reduce

Consensus Rating

PetMed Express has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

PetMed Express has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: -87.50%

Earnings Growth

Earnings for PetMed Express are expected to decrease by -87.50% in the coming year, from $0.24 to $0.03 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of PetMed Express is -79.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of PetMed Express is -79.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

PetMed Express has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

9.51% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 6.8.

Change versus previous month

Short interest in PetMed Express has recently decreased by 15.42%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PetMed Express does not currently pay a dividend.

Dividend Growth

PetMed Express does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.51% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 6.8.

Change versus previous month

Short interest in PetMed Express has recently decreased by 15.42%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for PetMed Express this week, compared to 3 articles on an average week.

Search Interest

Only 3 people have searched for PETS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, PetMed Express insiders have bought more of their company's stock than they have sold. Specifically, they have bought $41,750.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 1.10% of the stock of PetMed Express is held by insiders.

Percentage Held by Institutions

73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PETS Stock Analysis - Frequently Asked Questions

How have PETS shares performed this year?

PetMed Express' stock was trading at $7.56 at the start of the year. Since then, PETS stock has decreased by 36.8% and is now trading at $4.78.
View the best growth stocks for 2024 here.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) released its quarterly earnings data on Wednesday, November, 6th. The company reported $0.11 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.17. The firm earned $59.57 million during the quarter, compared to analysts' expectations of $66.02 million. PetMed Express had a negative trailing twelve-month return on equity of 1.00% and a negative net margin of 0.37%.

Who are PetMed Express' major shareholders?

Top institutional shareholders of PetMed Express include Hotchkis & Wiley Capital Management LLC (5.28%), Geode Capital Management LLC (1.07%), Charles Schwab Investment Management Inc. (1.00%) and Invenomic Capital Management LP (0.84%). Insiders that own company stock include Nina Capital Holdings Inc, Mathew N Hulett, Gian Fulgoni, Jacqueline Paula Smith and Christine Chambers.
View institutional ownership trends.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Meta Platforms (META), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Walt Disney (DIS), Ford Motor (F) and PayPal (PYPL).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 11/22/2024
• Fiscal Year End: 3/31/2025
• Next Earnings (Estimated): 4/21/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Retail/Wholesale
• Industry: Drug stores & proprietary stores
• Sub-Industry: Internet Retail
• Current Symbol: NASDAQ:PETS
• CUSIP: 71638210
• CIK: 1040130
• Web: www.1800petmeds.com
• Phone: (561) 526-4444
• Fax: 561-526-4445
• Employees: 287
• Year Founded: 1996

Price Target and Rating

• Average Stock Price Target: $3.50
• High Stock Price Target: $3.50
• Low Stock Price Target: $3.50
• Potential Upside/Downside: -24.6%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 19.33
• P/E Growth: N/A
• Net Income: $-7,460,000.00
• Net Margins: -0.37%
• Pretax Margin: -0.19%
• Return on Equity: -1.00%
• Return on Assets: -0.60%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.45
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $281.06 million
• Price / Sales: 0.34
• Cash Flow: $0.02 per share
• Price / Cash Flow: 198.76
• Book Value: $4.67 per share
• Price / Book: 0.99

Miscellaneous

• Outstanding Shares: 20,660,000
• Free Float: 20,436,000
• Market Cap: $95.86 million
• Optionable: Optionable
• Beta: 0.68